Who owns IMPEL NEUROPHARMA INC?
- Ticker: IMPLQ
- CUSIP Number: 45258k109
Tip: Access positions for across all investors
Analyze quarterly positions in Impel Neuropharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Impel Neuropharma stock
Who bought or sold IMPEL NEUROPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| venBio Partners | 2.8M | $341k | 0% | Dec 2023 |
|
| D. J. St. Germain | 1.5k | $184.950000 | 0% | Dec 2023 |
|
Who sold out of Impel Neuropharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Kohlberg Kravis Roberts & Co | Sep 2023 | 4.1M | $1.8M |
| NVP Associates | Sep 2023 | 3.1M | $1.3M |
| 5AM Venture Management | Sep 2023 | 2.9M | $1.2M |
| Vivo Capital | Sep 2023 | 2.9M | $1.2M |
| Vanguard Group | Sep 2023 | 505k | $217k |
| Bank of New York Mellon | Sep 2023 | 35k | $15k |
| Millennium Management | Sep 2023 | 22k | $9.2k |
| Two Sigma Securities | Sep 2023 | 21k | $8.8k |
| Virtu Financial | Sep 2023 | 16k | $7.0k |
| Raymond James & Associates | Sep 2023 | 15k | $6.2k |
| Captrust Financial Advisors | Sep 2023 | 14k | $6.2k |
| Brighton Jones | Sep 2023 | 14k | $6.1k |
| Lindbrook Capital | Sep 2023 | 3.1k | $1.3k |